Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eriko Takamine"'
Autor:
Daiki, Higuchi, Takuto, Matsuura, Eriko, Takamine, Mayu, Hosokawa, Kana, Kobori, Sadakatsu, Ikeda, Syunsuke, Harada, Koichi, Honma, Atsushi, Tajima, Masayuki, Yoshida, Isao, Otsuka
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(7)
Cowden syndrome is a rare autosomal dominant disorder characterized by multiple hamartomas in various tissues, including the skin, mucous membranes, and gastrointestinal tract. Germline mutations of the PTEN tumor suppressor gene are responsible for
Autor:
Mika Ohki, Eriko Takamine, Koichiro Kimura, Masayuki Yoshida, Kosuke Tanimoto, Satoshi Miyake, Iichiro Onishi, Yusuke Ebana, Kohta Yokoyama, Fuyuki Miya, Sadakatsu Ikeda, Susumu Kirimura, Rika Noji, Yamato Yamashita, Yoshihito Kano, Yumi Kobayashi, Akira Takemoto, Ryo Kudo, Makiko Egawa, Jyunko Yokobori, Yuko Kinowaki
Publikováno v:
Annals of Oncology. 32:S287
Autor:
Yuichi, Kumaki, Kenta, Takahashi, Takahiro, Mitsumura, Junko, Yokobori, Eriko, Takamine, Eri, Ishibashi, Hiroyuki, Sakashita, Toshiaki, Ishikawa, Hiroaki, Ono, Daisuke, Ban, Atsushi, Kudo, Noriko, Oshima, Tsuyoshi, Nakagawa, Koichiro, Kimura, Kazunori, Kubota, Iichiro, Onishi, Minoru, Tanabe, Hiroyuki, Uetake, Satoshi, Miyake, Sadakatsu, Ikeda
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(11)
FoundationOne CDx is a cancer genome profiling test that has already been approved by the FDA, but its clinical utility in Japanese patients is unknown. In this study, we examined the clinical utility of FoundationOne CDx.46 samples from 43 Japanese
Autor:
Daisuke Ban, Kousuke Tanimoto, Yoshihito Kano, Noriko Oshima, Akira Takemoto, Johji Inazawa, Atsushi Kudo, Satoshi Miyake, Minoru Tanabe, Naoyuki Miyasaka, Yuichi Kumaki, Iichiro Onishi, Junko Yokobori, Eriko Takamine, Yasuyuki Gen, Sadakatsu Ikeda, Kenta Takahashi
Publikováno v:
Journal of Clinical Oncology. 38:e15671-e15671
e15671 Background: Comprehensive genomic profiling (CGP) identified single nucleotide variants (SNVs), copy number alteration (CNA), indels, and rearrangements in cancer-related genes. Only limited CGP detects hemizygous deletion. Also panel size dif